Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHB2100171	卡格列净片	canagliflozin	Tablet	Chemical Drugs(4)	Supplementary Application	2021-01-25	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	Certificate Issued	2021-03-03	view
CYHB2100174	安立生坦片	ambrisentan	Tablet	Chemical Drugs(4)	Supplementary Application	2021-01-25	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	Certificate Issued	2021-03-03	view
CYHB2100173	阿哌沙班片	apixaban	Tablet	Chemical Drugs(原6)	Supplementary Application	2021-01-25	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	Certificate Issued	2021-03-03	view
CYHB2100172	卡格列净片	canagliflozin	Tablet	Chemical Drugs(4)	Supplementary Application	2021-01-25	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	Certificate Issued	2021-03-03	view
CXHL2100217	HS-10374片	HS-10374	Tablet	Chemical Drugs(1)	New Drug Application	2021-04-02	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	In Review	2021-04-01	view
CXHL2100216	HS-10374片	HS-10374	Tablet	Chemical Drugs(1)	New Drug Application	2021-04-02	常州恒邦药业有限公司	Changzhou Humon Pharmaceutical Co Ltd	In Review	2021-04-01	view